#US IPO — FinScans

📈 Stocks

Nscale Eyes September US IPO With $51 Billion Contract Backlog

August 6, 2026 (19 days ago)

Nscale's $51 billion contract pipeline signals robust demand ahead of its planned September US IPO, making it one of the year's most…

NSCALE

🌍 US Read More →

📈 Stocks

Latigo Biotech Files for $288M Nasdaq IPO to Fund Non-Opioid Pain Drugs

August 3, 2026 (22 days ago)

Latigo files for $288M US IPO to advance its non-opioid painkiller pipeline, capitalizing on strong investor interest in safer alternatives to addictive…

NDX

🌍 US Read More →

📈 Stocks

A16z-Backed Braveheart Biotech Seeks $318.8 Million in US IPO

July 30, 2026 (26 days ago)

A16z-backed Braveheart seeks $318.8 million in a US IPO, signaling continued vigor in the venture-backed biotech market.

BRAVEHEART

🌍 US Read More →

📈 Stocks

Accor Taps Banks for Hoxton Owner Ennismore’s US IPO

July 8, 2026 (48 days ago)

Accor taps banks for a US IPO of Hoxton owner Ennismore, signaling hospitality sector confidence and potentially unlocking shareholder value.

ACCOR

🌍 US Read More →

📈 Stocks

Parabilis Scores $745 Million in US IPO, Boosting Biotech Sector

June 10, 2026 (77 days ago)

Parabilis completes $745 million US IPO, indicating robust biotech investor appetite and potential gains for biotech ETFs.

PARABILIS IBB

🌍 US Read More →

📈 Stocks

SoftBank-Backed Firm Files for U.S. IPO to Fuel Data Center Expansion

May 21, 2026 (97 days ago)

A SoftBank-backed company files for a U.S. initial public offering as it seeks to ride the wave of data center demand fueled…

SFTBY EQIX DLR

🌍 US Read More →